CL
VRTX icon

Choreo LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

Choreo LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.22M Buy
6,474
+308
+5% +$137K 0.04% 309
2026
Q1 		$2.75M Sell
6,166
-842
-12% -$393K 0.03% 322
2025
Q4 		$3.18M Buy
7,008
+1,154
+20% +$497K 0.04% 270
2025
Q3 		$2.29M Sell
5,854
-499
-8% -$209K 0.03% 344
2025
Q2 		$2.83M Sell
6,353
-40
-0.6% -$18.4K 0.04% 286
2025
Q1 		$3.1M Buy
6,393
+301
+5% +$140K 0.05% 256
2024
Q4 		$2.43M Buy
6,092
+154
+3% +$71.4K 0.04% 306
2024
Q3 		$2.79M Buy
5,938
+1,590
+37% +$764K 0.04% 281
2024
Q2 		$2.05M Buy
4,348
+3,858
+787% +$1.67M 0.03% 315
2024
Q1 		$205K Buy
+490
New +$207K 0.01% 625

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Choreo LLC's VRTX Position: Q2 2026 in Review

Choreo LLC increased its Vertex Pharmaceuticals (VRTX) stake by 5% in Q2 2026, buying an estimated $137K and bringing the position to 6,474 shares worth $3.22M. The position accounts for 0.04% of the portfolio, ranked #309.

Choreo LLC first reported a position in VRTX in Q1 2024 and has held it in 10 quarters since. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Choreo LLC held 6,474 shares of Vertex Pharmaceuticals worth $3.22M as of Q2 2026.
  • Choreo LLC bought 308 Vertex Pharmaceuticals shares in Q2 2026, an estimated $137K.
  • Vertex Pharmaceuticals made up 0.04% of Choreo LLC's portfolio in Q2 2026, its #309 holding.
  • Choreo LLC first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.